tiprankstipranks
Trending News
More News >

ProKidney sees cash runway into mid-2027

Cash, cash equivalents and marketable securities as of December 31, 2024, totaled $358.3 million, compared to $363.0 million on December 31, 2023. We expect that our existing cash, cash equivalents and marketable securities held at December 31, 2024, will enable us to fund our operating expenses and capital expenditure requirements into mid-2027.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue